Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, octubre 24
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
ICU Medical Inc
ICUI
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$166.62
-1.71
-1.02%
Últ. Act.: Oct 23, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 12 días de ahora en jue nov 5th, después del cierre del mercado
ICU Medical Financials
ICU Medical (ICUI) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.
Avi Kapoor
PRO
ICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 Est
ICU Medical (NASDAQ:ICUI) raises FY2026 Adj EPS guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 analyst estimate..
Benzinga Newsdesk
PRO
ICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 Est
ICU Medical (NASDAQ:ICUI) raises FY2026 GAAP EPS guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 analyst estimate..
Benzinga Newsdesk
PRO
ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate
ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 by 24.08 percent. This is a 12.86 percent increase over earnings of $2.10 per share from the
Benzinga Newsdesk
PRO
ICU Medical Affirms FY2026 GAAP EPS Guidance of $1.03-$1.74 vs $1.73 Est
ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $1.03-$1.74 to $1.03-$1.74 vs $1.73 analyst estimate..
Benzinga Newsdesk
PRO
ICU Medical Affirms FY2026 Adj EPS Guidance of $7.75-$8.45 vs $8.09 Est
ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $7.75-$8.45 to $7.75-$8.45 vs $8.09 analyst estimate..
Benzinga Newsdesk
